2nd May 2008 10:28
Skyepharma PLC02 May 2008 For Immediate Release 2 May 2008 SkyePharma PLC ("the Company") The Company was informed on 30 April 2008 that as a result of transactions on 30April 2008 by the SkyePharma PLC Share Purchase Plan (an approved all employeeshare purchase plan) the Trustees of the Plan purchased an additional 14,046Ordinary Shares of the Company at a price of 10.25 pence per share. Following these transactions, the Trustees hold on behalf of the Plan, 217,962Ordinary Shares representing 0.027% of the share capital of the Company. Theclass of discretionary beneficiaries for whom the Trustees hold such sharesconsists of employees of the Company, including the following ExecutiveDirectors: Frank Condella and Peter Grant. As a result of these transactions, the following Executive Directors have thefollowing additional interests as a result of their personal participation inthe Plan:- Partnership Shares Matching Shares awarded Total number of purchased on 30 April on 30 April 2008 at Partnership and Matching 2008 at 10.25p per 10.25p per share Shares held on 30 April share 2008 Frank Condella 1219 1219 31,408Peter Grant 1219 1219 24,036 In accordance with the rules of the Plan these Directors have been awardedMatching Shares on the basis of one Matching Share (Ordinary Share) for eachPartnership Share (Ordinary Share). The beneficial ownership of the Matching Shares will pass to the Directors inthree years' time subject to continued employment and the retention of theunderlying Partnership Shares. The execution of the transaction noted above did not involve any of theCompany's Directors or any persons discharging managerial responsibility. This notification relates to transactions notified in accordance withDisclosure and Transparency Rule 3.1.4R(1)(a). This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L